Michelle Johnson

Michelle Johnson is a seasoned business leader with extensive experience in the pharmaceutical and healthcare sectors. Currently serving as Senior Regional Business Director at Karyopharm Therapeutics Inc. since January 2019, Michelle has previously held roles at Teva Pharmaceuticals, Triad Isotopes, General Electric-GE Healthcare, Santarus Pharmaceuticals, Aventis Pharmaceuticals, and Innovex Pharmaceuticals. Key accomplishments include achieving 125% of sales goals at Teva, significantly increasing Bendeka usage, and successfully converting multiple high-profile accounts. With a Bachelor of Science in Psychology from UC Irvine, Michelle possesses a strong blend of strategic sales expertise and account management skills within the oncology and diagnostics markets.